Since significant changes in transcript and protein expression of RECK and proangiogenic molecules were observed after 12 weeks of DMBA painting that correlated with tumour progression, we tested the chemotherapeutic efficacy of nimbolide at this time point. The gene discussed is RECK; the disease is neoplasm.